Literature DB >> 23328531

Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation.

Aric L Gregson1, Xiaoyan Wang, S Sam Weigt, Vyacheslav Palchevskiy, Joseph P Lynch, David J Ross, Bernard M Kubak, Rajan Saggar, Michael C Fishbein, Abbas Ardehali, Gang Li, Robert Elashoff, John A Belperio.   

Abstract

RATIONALE: Pseudomonas aeruginosa is the most commonly isolated gram-negative bacterium after lung transplantation and has been shown to up-regulate glutamic acid-leucine-arginine-positive (ELR(+)) CXC chemokines associated with bronchiolitis obliterans syndrome (BOS), but the effect of pseudomonas on BOS and death has not been well defined.
OBJECTIVES: To determine if the influence of pseudomonas isolation and ELR(+) CXC chemokines on the subsequent development of BOS and the occurrence of death is time dependent.
METHODS: A three-state model was developed to assess the likelihood of transitioning from lung transplant (state 1) to BOS (state 2), from transplant (state 1) to death (state 3), and from BOS (state 2) to death (state 3). This Cox semi-Markovian approach determines state survival rates and cause-specific hazards for movement from one state to another.
MEASUREMENTS AND MAIN RESULTS: The likelihood of transition from transplant to BOS was increased by acute rejection, CXCL5, and the interaction between pseudomonas and CXCL1. The pseudomonas effect in this transition was due to infection rather than colonization. Movement from transplant to death was facilitated by pseudomonas infection and single lung transplant. Transition from BOS to death was affected by the length of time in state 1 and by the interactions between any pseudomonas isolation and CXCL5 and aspergillus, either independently or in combination.
CONCLUSIONS: Our model demonstrates that common post-transplantation events drive movement from one post-transplantation state to another and influence outcomes differently depending upon when after transplantation they occur. Pseudomonas and the ELR(+) CXC chemokines may interact to negatively influence lung transplant outcomes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23328531      PMCID: PMC3733405          DOI: 10.1164/rccm.201207-1228OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  43 in total

Review 1.  Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria.

Authors:  Marc Estenne; Janet R Maurer; Annette Boehler; James J Egan; Adaani Frost; Marshall Hertz; George B Mallory; Gregory I Snell; Samuel Yousem
Journal:  J Heart Lung Transplant       Date:  2002-03       Impact factor: 10.247

2.  A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation.

Authors:  R Vos; B M Vanaudenaerde; S E Verleden; S I De Vleeschauwer; A Willems-Widyastuti; D E Van Raemdonck; A Schoonis; T S Nawrot; L J Dupont; G M Verleden
Journal:  Eur Respir J       Date:  2010-06-18       Impact factor: 16.671

3.  CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction.

Authors:  S S Weigt; A Derhovanessian; E Liao; S Hu; A L Gregson; B M Kubak; R Saggar; R Saggar; V Plachevskiy; M C Fishbein; J P Lynch; A Ardehali; D J Ross; H-J Wang; R M Elashoff; J A Belperio
Journal:  Am J Transplant       Date:  2011-12-07       Impact factor: 8.086

4.  Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.

Authors:  Shawn D Aaron; Katherine L Vandemheen; Karam Ramotar; Tracy Giesbrecht-Lewis; Elizabeth Tullis; Andreas Freitag; Nigel Paterson; Mary Jackson; M Diane Lougheed; Christopher Dowson; Vijay Kumar; Wendy Ferris; Francis Chan; Steve Doucette; Dean Fergusson
Journal:  JAMA       Date:  2010-11-17       Impact factor: 56.272

5.  Impaired interleukin-8 chemokine secretion by staphylococcus aureus-activated epithelium and T-cell chemotaxis in cystic fibrosis.

Authors:  Denise Al Alam; Gaetan Deslee; Claire Tournois; Bouchaib Lamkhioued; François Lebargy; Marc Merten; Azzaq Belaaouaj; Moncef Guenounou; Sophie Catherine Gangloff
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-13       Impact factor: 6.914

6.  Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.

Authors:  Michael P Keane; John A Belperio; Ying Y Xue; Marie D Burdick; Robert M Strieter
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

7.  Protection against bronchiolitis obliterans syndrome is associated with allograft CCR7+ CD45RA- T regulatory cells.

Authors:  Aric L Gregson; Aki Hoji; Vyacheslav Palchevskiy; Scott Hu; S Samuel Weigt; Eileen Liao; Ariss Derhovanessian; Rajeev Saggar; Sophie Song; Robert Elashoff; Otto O Yang; John A Belperio
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

8.  CXCR2 is critical to hyperoxia-induced lung injury.

Authors:  Richard D Sue; John A Belperio; Marie D Burdick; Lynne A Murray; Ying Ying Xue; Maria C Dy; Jeffery J Kwon; Michael P Keane; Robert M Strieter
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

9.  Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome.

Authors:  Michael P Keane; Seamas C Donnelly; John A Belperio; Richard B Goodman; Maria Dy; Marie D Burdick; Michael C Fishbein; Robert M Strieter
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

10.  Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation.

Authors:  S S Weigt; R M Elashoff; M P Keane; R M Strieter; B N Gomperts; Y Y Xue; A Ardehali; A L Gregson; B Kubak; M C Fishbein; R Saggar; D J Ross; J P Lynch; D A Zisman; J A Belperio
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

View more
  28 in total

1.  Altered Exosomal RNA Profiles in Bronchoalveolar Lavage from Lung Transplants with Acute Rejection.

Authors:  Aric L Gregson; Aki Hoji; Patil Injean; Steven T Poynter; Claudia Briones; Vyacheslav Palchevskiy; S Sam Weigt; Michael Y Shino; Ariss Derhovanessian; David Sayah; Rajan Saggar; David Ross; Abbas Ardehali; Joseph P Lynch; John A Belperio
Journal:  Am J Respir Crit Care Med       Date:  2015-12-15       Impact factor: 21.405

2.  A severe Mycoplasma pneumoniae pneumonia inducing an acute antibody-mediated pulmonary graft rejection.

Authors:  Sarah Démir; Julien Saison; Agathe Sénéchal; Jean-Francois Mornex
Journal:  Lung India       Date:  2017 Jan-Feb

3.  Update in lung transplantation 2013.

Authors:  Jamie L Todd; Jason D Christie; Scott M Palmer
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

Review 4.  The lung microbiome after lung transplantation.

Authors:  Julia Becker; Valeriy Poroyko; Sangeeta Bhorade
Journal:  Expert Rev Respir Med       Date:  2014-04       Impact factor: 3.772

5.  Staphylococcus via an interaction with the ELR+ CXC chemokine ENA-78 is associated with BOS.

Authors:  A L Gregson; X Wang; P Injean; S S Weigt; M Shino; D Sayah; A DerHovanessian; J P Lynch; D J Ross; R Saggar; A Ardehali; G Li; R Elashoff; J A Belperio
Journal:  Am J Transplant       Date:  2015-02-12       Impact factor: 8.086

6.  Host-Pathogen Interactions and Chronic Lung Allograft Dysfunction.

Authors:  John Belperio; Scott M Palmer; S Sam Weigt
Journal:  Ann Am Thorac Soc       Date:  2017-09

7.  Gene Expression Profiling of Bronchoalveolar Lavage Cells During Aspergillus Colonization of the Lung Allograft.

Authors:  S Samuel Weigt; Xiaoyan Wang; Vyacheslav Palchevskiy; Naman Patel; Ariss Derhovanessian; Michael Y Shino; David M Sayah; Joseph P Lynch; Rajan Saggar; David J Ross; Bernie M Kubak; Abbas Ardehali; Scott Palmer; Shahid Husain; John A Belperio
Journal:  Transplantation       Date:  2018-06       Impact factor: 4.939

Review 8.  Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction.

Authors:  S Samuel Weigt; Vyacheslav Palchevskiy; John A Belperio
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

9.  Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation.

Authors:  Paul R Allyn; Erin L Duffy; Romney M Humphries; Patil Injean; S Samuel Weigt; Rajan Saggar; Michael Y Shino; Joseph P Lynch; Abbas Ardehali; Bernard Kubak; Chi-Hong Tseng; John A Belperio; David J Ross; Aric L Gregson
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

10.  Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation.

Authors:  Hrishikesh S Kulkarni; Kevin Tsui; Suraj Sunder; Alex Ganninger; Laneshia K Tague; Chad A Witt; Derek E Byers; Elbert P Trulock; Ruben Nava; Varun Puri; Daniel Kreisel; Thalachallour Mohanakumar; Andrew E Gelman; Ramsey R Hachem
Journal:  Am J Transplant       Date:  2019-12-24       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.